These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8771599)

  • 1. Follow-up assessment of medication-treated dysthymia.
    Hellerstein DJ; Samstag LW; Cantillon M; Maurer M; Rosenthal J; Yanowitch P; Winston A
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Apr; 20(3):427-42. PubMed ID: 8771599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of serotonergic antidepressants in treatment of dysthymia.
    Rosenthal J; Hemlock C; Hellerstein DJ; Yanowitch P; Kasch K; Schupak C; Samstag L; Winston A
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):933-41. PubMed ID: 1513932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of double depression: a preliminary study with serotonergic antidepressants.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Hemlock C; Kasch K; Samstag LW; Winston A
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):139-47. PubMed ID: 8115668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine treatment of dysthymia in the elderly.
    Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
    J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bipolar disorder: clinical trials with fluoxetine].
    Ambrosio LA; Buccomino D; Filippo A; Filippo P; Marchese G; Barrese E; Paoletti C; Colonna CV
    Minerva Psichiatr; 1992; 33(4):305-12. PubMed ID: 1297908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How long should patients with psychotic depression stay on the antipsychotic medication?
    Rothschild AJ; Duval SE
    J Clin Psychiatry; 2003 Apr; 64(4):390-6. PubMed ID: 12716238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety findings from naturalistic fluoxetine drug treatment in adolescent and young adult patients.
    Dittmann RW; Czekalla J; Hundemer HP; Linden M
    J Child Adolesc Psychopharmacol; 2000; 10(2):91-102. PubMed ID: 10933119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Wagner G
    J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
    Rabkin JG; Wagner GJ; Rabkin R
    Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.